Heterotropic activation of flavonoids on cytochrome P450 3A4: A case example of alleviating dronedarone-induced cytotoxicity

Toxicol Lett. 2020 Feb 1:319:187-196. doi: 10.1016/j.toxlet.2019.11.016. Epub 2019 Nov 19.

Abstract

The clinical drug-drug interactions mediated by heterotropic activation on cytochrome P450 (CYP450) kinetics, especially CYP3A4, have received wide concern in recent years. Flavonoids, a group of important natural substances with various pharmacological activities, distribute widely among vegetables, fruits and herbs. The frequent and numerous uses of flavonoids may increase the risk of food/herb-drug interactions. However, little is known about activation effects of flavonoids on CYP3A4. The aim of this study was to investigate activation of CYP3A4 by flavonoids, explore the molecular mechanism, and assess the biological effects on dronedarone (DND) induced toxicity. The results showed that flavone, tangeretin, sinensetin and 6-hydroxyflavone increased the cell viability by decreasing DND-induced cytotoxicity. These four flavonoids could activate the metabolism of DND in hamster pharmacokinetics study. Furthermore, both molecular docking and circular dichroism analysis partially illustrated the molecular mechanism of heterotropic activation. Finally, the pharmacophore model suggested B aromatic ring, hydrophobic groups at 7-position and hydrogen bond acceptors at 4-position may play a vital role in activation of flavonoids on CYP3A4. Taken together, our findings would provide useful information for predicting the potential risks of flavonoid-containing food/herb-drug interactions in humans.

Keywords: Cytochrome P450 3A4; Dronedarone; Flavonoids; Heterotropic activation; Molecular mechanism.

MeSH terms

  • Animals
  • Anti-Arrhythmia Agents / pharmacokinetics
  • Anti-Arrhythmia Agents / toxicity*
  • Cell Survival / drug effects*
  • Circular Dichroism
  • Cricetinae
  • Cytochrome P-450 CYP3A / metabolism*
  • Dronedarone / pharmacokinetics
  • Dronedarone / toxicity*
  • Enzyme Activation
  • Enzyme Activators / pharmacology*
  • Flavonoids / pharmacology*
  • Herb-Drug Interactions
  • Hydrogen Bonding
  • Male
  • Mesocricetus
  • Models, Molecular
  • Molecular Docking Simulation

Substances

  • Anti-Arrhythmia Agents
  • Enzyme Activators
  • Flavonoids
  • Cytochrome P-450 CYP3A
  • Dronedarone